Free tool
Drug Trial Radar: Dermatology
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
3
Recruiting, industry sponsors, Dermatology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
3 trials
Showing 1 to 3, recently updated first.
IR INNOVATE RESEARCH PRIVATE LIMITEDIndustry
NCT07918001 · 225 participants (planned) · Start Feb 25, 2026 · Primary completion Feb 28, 2027
Drug: Klenzit®-C (Adapalene/Clindamycin Phosphate Gel) · For: Acne
Sites: Hanoi, Vietnam; Ho Chi Minh City, Vietnam · 3 sites in all
Bausch Health Americas, Inc.Industry
NCT07524946 · 100 participants (planned) · Start Apr 1, 2026 · Primary completion Dec 2027
Drug: CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%. · For: Acne Vulgaris
Sites: Bryant, Arkansas; Rogers, Arkansas; Freemont, California · 15 sites in all
Integrative Skin Science and ResearchIndustry
NCT07544251 · 30 participants (planned) · Start Apr 20, 2026 · Primary completion Apr 2027
Drug: Sarecycline; Doxycycline · For: Acne Vulgaris
Sites: Sacramento, California
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.